CARDIOXANE Trademark

Trademark Overview

On Friday, April 8, 2016, a trademark application was filed for CARDIOXANE with the United States Patent and Trademark Office. The USPTO has given the CARDIOXANE trademark a serial number of 86969771. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, March 21, 2025. This trademark is owned by Clinigen Healthcare Limited. The CARDIOXANE trademark is filed in the Pharmaceutical Products category with the following description:

PHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CANCER
cardioxane

General Information

Serial Number86969771
Word MarkCARDIOXANE
Filing DateFriday, April 8, 2016
Status710 - CANCELLED - SECTION 8
Status DateFriday, March 21, 2025
Registration Number5561522
Registration DateTuesday, September 11, 2018
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 14, 2017

Trademark Statements

Goods and ServicesPHARMACEUTICAL PREPARATIONS AND SUBSTANCES FOR THE TREATMENT OF CANCER

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, March 21, 2025
Primary Code005
First Use Anywhere DateThursday, December 31, 1992
First Use In Commerce DateFriday, August 4, 2017

Trademark Owner History

Party NameCNX THERAPEUTICS LIMITED
Party Type31 - New Owner After Registration
Legal Entity Type11 - Company
AddressLONDON EC1Y 8YZ
GB
Party NameClinigen Healthcare Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressStaffordshire DE142WW
GB
Party NameClinigen Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressStaffordshire DE142WW
GB
Party NameClinigen Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressStaffordshire DE142WW
GB

Trademark Events

Event DateEvent Description
Tuesday, April 12, 2016NEW APPLICATION ENTERED
Thursday, April 14, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 22, 2016ASSIGNED TO EXAMINER
Wednesday, July 27, 2016NON-FINAL ACTION WRITTEN
Wednesday, July 27, 2016NON-FINAL ACTION E-MAILED
Wednesday, July 27, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 27, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 10, 2017ASSIGNED TO LIE
Wednesday, February 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 15, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, March 8, 2017SUSPENSION LETTER WRITTEN
Wednesday, March 8, 2017LETTER OF SUSPENSION E-MAILED
Wednesday, March 8, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Tuesday, September 19, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Tuesday, October 10, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 25, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 14, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 14, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 9, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, July 2, 2018TEAS STATEMENT OF USE RECEIVED
Monday, July 2, 2018USE AMENDMENT FILED
Wednesday, July 25, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 25, 2018STATEMENT OF USE PROCESSING COMPLETE
Friday, August 3, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Saturday, August 4, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, September 11, 2018REGISTERED-PRINCIPAL REGISTER
Monday, September 11, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Wednesday, November 8, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Friday, March 21, 2025CANCELLED SEC. 8 (6-YR)

Related Keywords

cardioxane cancer treatment substances preparations pharmaceutical